Nlgn3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Neuroligin-3 (NLGN3) is a postsynaptic cell adhesion molecule that is widely expressed throughout the brain and plays important roles in both excitatory and inhibitory synaptic transmission. NLGN3 is unique among neuroligin family members in its ability to bind to both neurexins and other adhesion molecules, and it has been implicated in various aspects of synaptic function, including synapse formation, stabilization, and plasticity. NLGN3 is encoded by the NLGN3 gene on chromosome Xq13.1 and is expressed at high levels in the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum. Mutations in NLGN3 have been linked to autism spectrum disorder (ASD) and intellectual disability, making it an important gene in understanding neurodevelopmental disorders. [@tabuchi2007]
Basic Information
Protein Structure
NLGN3 is a type I transmembrane protein with the characteristic neuroligin architecture:
Extracellular Domain: Large extracellular region (~750 amino acids) containing the acetylcholinesterase-like (AChE-like) domain that mediates trans-synaptic interactions with presynaptic partners including neurexins.
Transmembrane Domain: Single-pass transmembrane helix that anchors the protein in the postsynaptic membrane.
PDZ domain-binding motif for interaction with scaffolding proteins
Multiple serine/threonine phosphorylation sites
Interaction sites for various intracellular signaling molecules
Normal Function
NLGN3 plays several critical roles in synaptic function:
Synapse Formation: Mediates formation of both excitatory and inhibitory synapses by binding to presynaptic neurexins.
Synaptic Transmission: Regulates neurotransmitter release and postsynaptic receptor clustering.
Synaptic Plasticity: Involved in activity-dependent changes in synaptic strength.
Circuit Assembly: Critical for proper neural circuit formation during development.
Disease Associations
Therapeutic Implications
NLGN3 represents a potential therapeutic target for neurodevelopmental disorders. Approaches being explored include:
Gene Therapy: Delivery of functional NLGN3 to restore synaptic function
Small Molecule Modulators: Development of compounds that enhance NLGN3 function
Protein Replacement: Exogenous protein delivery to compensate for loss-of-function
Background
The study of Nlgn3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Jamain S, et al, Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism (2003)](https://doi.org/10.1038/ng1136)
[Tabuchi K, et al, A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice (2007)](https://doi.org/10.1126/science.1146221)
[aram J, et al, Neuroligin-3 is required for synaptic plasticity (2014)](https://doi.org/10.1016/j.neuron.2014.04.001)
[Baudouin SJ, et al, Shared synaptic pathophysiology in syndromic and nonsyndromic models of autism (2012)](https://doi.org/10.1126/science.1224159)
[Etherton M, et al, Autism-linked neuroligin-3 R451C mutation differentially impacts development of excitatory and inhibitory synaptic circuits (2011)](https://doi.org/10.1038/nn.2876)